232 related articles for article (PubMed ID: 25431946)
1. Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy.
Consalvi S; Saccone V; Mozzetta C
Epigenomics; 2014; 6(5):547-60. PubMed ID: 25431946
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients.
Mozzetta C; Sartorelli V; Steinkuhler C; Puri PL
Trends Mol Med; 2024 Mar; 30(3):278-294. PubMed ID: 38408879
[TBL] [Abstract][Full Text] [Related]
3. Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro-adipogenic progenitors.
Consalvi S; Tucciarone L; Macrì E; De Bardi M; Picozza M; Salvatori I; Renzini A; Valente S; Mai A; Moresi V; Puri PL
EMBO Rep; 2022 Jun; 23(6):e54721. PubMed ID: 35383427
[TBL] [Abstract][Full Text] [Related]
4. G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy.
Hayashiji N; Yuasa S; Miyagoe-Suzuki Y; Hara M; Ito N; Hashimoto H; Kusumoto D; Seki T; Tohyama S; Kodaira M; Kunitomi A; Kashimura S; Takei M; Saito Y; Okata S; Egashira T; Endo J; Sasaoka T; Takeda S; Fukuda K
Nat Commun; 2015 Apr; 6():6745. PubMed ID: 25865621
[TBL] [Abstract][Full Text] [Related]
5. A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy.
Farr GH; Morris M; Gomez A; Pham T; Kilroy E; Parker EU; Said S; Henry C; Maves L
Skelet Muscle; 2020 Oct; 10(1):29. PubMed ID: 33059738
[TBL] [Abstract][Full Text] [Related]
6. Concise Review: Epigenetic Regulation of Myogenesis in Health and Disease.
Sincennes MC; Brun CE; Rudnicki MA
Stem Cells Transl Med; 2016 Mar; 5(3):282-90. PubMed ID: 26798058
[TBL] [Abstract][Full Text] [Related]
7. Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy.
Giovarelli M; Zecchini S; Catarinella G; Moscheni C; Sartori P; Barbieri C; Roux-Biejat P; Napoli A; Vantaggiato C; Cervia D; Perrotta C; Clementi E; Latella L; De Palma C
Pharmacol Res; 2021 Aug; 170():105751. PubMed ID: 34197911
[TBL] [Abstract][Full Text] [Related]
8. Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies.
Sandonà M; Cavioli G; Renzini A; Cedola A; Gigli G; Coletti D; McKinsey TA; Moresi V; Saccone V
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901738
[TBL] [Abstract][Full Text] [Related]
9. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.
Colussi C; Mozzetta C; Gurtner A; Illi B; Rosati J; Straino S; Ragone G; Pescatori M; Zaccagnini G; Antonini A; Minetti G; Martelli F; Piaggio G; Gallinari P; Steinkuhler C; Clementi E; Dell'Aversana C; Altucci L; Mai A; Capogrossi MC; Puri PL; Gaetano C
Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19183-7. PubMed ID: 19047631
[TBL] [Abstract][Full Text] [Related]
10. Histological effects of givinostat in boys with Duchenne muscular dystrophy.
Bettica P; Petrini S; D'Oria V; D'Amico A; Catteruccia M; Pane M; Sivo S; Magri F; Brajkovic S; Messina S; Vita GL; Gatti B; Moggio M; Puri PL; Rocchetti M; De Nicolao G; Vita G; Comi GP; Bertini E; Mercuri E
Neuromuscul Disord; 2016 Oct; 26(10):643-649. PubMed ID: 27566866
[TBL] [Abstract][Full Text] [Related]
11. Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat.
Consalvi S; Mozzetta C; Bettica P; Germani M; Fiorentini F; Del Bene F; Rocchetti M; Leoni F; Monzani V; Mascagni P; Puri PL; Saccone V
Mol Med; 2013 May; 19(1):79-87. PubMed ID: 23552722
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases.
Consalvi S; Saccone V; Giordani L; Minetti G; Mozzetta C; Puri PL
Mol Med; 2011; 17(5-6):457-65. PubMed ID: 21308150
[TBL] [Abstract][Full Text] [Related]
13. Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy.
Spreafico M; Cafora M; Bragato C; Capitanio D; Marasca F; Bodega B; De Palma C; Mora M; Gelfi C; Marozzi A; Pistocchi A
Pharmacol Res; 2021 Aug; 170():105750. PubMed ID: 34214631
[TBL] [Abstract][Full Text] [Related]
14. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles.
Saccone V; Consalvi S; Giordani L; Mozzetta C; Barozzi I; Sandoná M; Ryan T; Rojas-Muñoz A; Madaro L; Fasanaro P; Borsellino G; De Bardi M; Frigè G; Termanini A; Sun X; Rossant J; Bruneau BG; Mercola M; Minucci S; Puri PL
Genes Dev; 2014 Apr; 28(8):841-57. PubMed ID: 24682306
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy.
Rugowska A; Starosta A; Konieczny P
Clin Epigenetics; 2021 Jan; 13(1):13. PubMed ID: 33468200
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
17. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice.
Liu N; Williams AH; Maxeiner JM; Bezprozvannaya S; Shelton JM; Richardson JA; Bassel-Duby R; Olson EN
J Clin Invest; 2012 Jun; 122(6):2054-65. PubMed ID: 22546853
[TBL] [Abstract][Full Text] [Related]
18. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy.
Vianello S; Yu H; Voisin V; Haddad H; He X; Foutz AS; Sebrié C; Gillet B; Roulot M; Fougerousse F; Perronnet C; Vaillend C; Matecki S; Escolar D; Bossi L; Israël M; de la Porte S
FASEB J; 2013 Jun; 27(6):2256-69. PubMed ID: 23430975
[TBL] [Abstract][Full Text] [Related]
19. Macrophages fine tune satellite cell fate in dystrophic skeletal muscle of mdx mice.
Madaro L; Torcinaro A; De Bardi M; Contino FF; Pelizzola M; Diaferia GR; Imeneo G; Bouchè M; Puri PL; De Santa F
PLoS Genet; 2019 Oct; 15(10):e1008408. PubMed ID: 31626629
[TBL] [Abstract][Full Text] [Related]
20. Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy.
Sugihara H; Teramoto N; Nakamura K; Shiga T; Shirakawa T; Matsuo M; Ogasawara M; Nishino I; Matsuwaki T; Nishihara M; Yamanouchi K
Sci Rep; 2020 Oct; 10(1):16385. PubMed ID: 33046751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
